Why Venomous Snake Bites Are Becoming Deadlier Than Ever

The Doctors Without Borders have exposed an essential fact in the arena of health which states that individuals, particularly in the developing countries might be exposed to health risks which are caused by snake bites.

A statement was issued on Monday, which exposed and eventually cautioned that the current accumulations of the anti-venom titled as Fav-Afrique, which was produced by Sanofi Pasteur will ultimately terminate in June. This modification is observed as the company has put a halt in making the anti-venoms and switched to producing rabies treatment for the disadvantaged.

This news has spread like wild fire as the necessity and usage of the anti-venom substances are considered as an essential drug, especially in tropical regions. The company is now facing a crisis and unfortunately, there is no other alternative to get out of this hurdle.

The issue became highlighted when the existing pharmaceutical company stood with other competitors who were determined to produce another anti-venom substance. Undoubtedly, they were much cheaper, thus rendering it less effective for the wounded, but much more in demand as compared to the antidote manufactured by Pasteur.

About 5 million people are bitten by snakes every year, which often results in death as well as in a lifelong injury. The company is not going to create another antidote for the next two years and that is why they have decided to transfer their anti-venom technology and ingredients to others so that majority lives could be saved by the snake bites.

This treatment is unquestionably expensive, but for other developing and poor countries, the drug is often bought by the aid companies and distributed to those in need. Also titled as MSF, the company's heads are determined to assure the availability of the treatment where needed. MSF called for international agencies in a meeting in Switzerland to make sure that the concerned have the direct access to the mentioned treatment.

According to international health agents, the need of anti-venom is increasing day by day as it can save the life of millions of wounded. Gregory Hartl, the spokesman of WHO claims that donors are often seen uninterested in buying the treatment and in some cases, doctors are also seen reluctant using them as according to them, they are derived from the wrong snake.